Pink Sheet Podcast: Bluebird Leaves Europe, Lilly’s Olympic TV Ads, Most Favored Nation Rule Pulled

Pink Sheet reporters and editors discuss Bluebird Bio’s decision to pull is gene therapy business from Europe, Eli Lilly potentially pushing regulatory boundaries with its Olympic TV spots, and the CMS decision to scrap the Trump Administration’s most favored nation rule.